RT Journal Article
SR Electronic
T1 Maternal smoking DNA methylation risk score associated with health outcomes in offspring of European and South Asian ancestry
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.24.23295907
DO 10.1101/2023.09.24.23295907
A1 Deng, Wei Q.
A1 Cawte, Nathan
A1 Campbell, Natalie
A1 Azab, Sandi M.
A1 de Souza, Russell J
A1 Lamri, Amel
A1 Morrison, Katherine M.
A1 Atkinson, Stephanie A.
A1 Subbarao, Padmaja
A1 Turvey, Stuart E.
A1 Moraes, Theo J.
A1 Teo, Koon K.
A1 Mandhane, Piush
A1 Azad, Meghan B.
A1 Simons, Elinor
A1 Pare, Guillaume
A1 Anand, Sonia S.
YR 2024
UL http://medrxiv.org/content/early/2024/05/24/2023.09.24.23295907.abstract
AB Maternal smoking has been linked to adverse health outcomes in newborns but the extent to which it impacts newborn health has not been quantified through an aggregated cord blood DNA methylation (DNAm) score. Here we examine the feasibility of using cord blood DNAm scores leveraging large external studies as discovery samples to capture the epigenetic signature of maternal smoking and its influence on newborns in White European and South Asian populations. We first examined association between individual CpGs and cigarette smoking during pregnancy, smoking exposure in two White European birth cohorts (n = 744). Several previously reported genes for maternal smoking were supported, with the strongest and most consistent signal from the GFI1 gene (6 CpGs with p < 5×10-5). Leveraging established CpGs for maternal smoking, we constructed a cord blood epigenetic score of maternal smoking that was validated in one of the European-origin cohorts (n = 347). This score was then tested for association with smoking status, secondary smoking exposure during pregnancy, and health outcomes in offspring measured after birth in an independent white European (n = 397) and a South Asian birth cohort (n = 504). The epigenetic maternal smoking score was strongly associated with smoking status during pregnancy (OR=1.09 [1.07,1.10], p=5.5×10-33) and more hours of self-reported smoking exposure per week (1.93 [1.27, 2.58], p=7.8×10-9) in White Europeans, but not with self-reported exposure (p > 0.05) in South Asians. The same score was consistently associated with a smaller birth size (−0.37±0.12 cm, p=0.0023) in the South Asian cohort and a lower birth weight (−0.043±0.013kg, p=0.0011) in the combined cohorts. This cord blood epigenetic score can help identify babies exposed to maternal smoking and assess its long-term impact on growth. Notably, these results indicate a consistent association between the DNAm signature of maternal smoking and a small body size and low birthweight in newborns, in both white European mothers who exhibited some amount of smoking and in South Asian mothers who themselves were not active smokers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Canadian Institutes of Health Research Metabolomics Team Grant: MWG-146332.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval: McMaster University. Ethical approval was obtained independently for all studies from the Hamilton Integrated Research Ethics Board CHILD (REB 07-2929), FAMILY (REB 02-060), START (REB 10-640).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes